These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3535917)

  • 1. Pharmacokinetics of insulin following intravenous and subcutaneous administration in canines.
    Ravis WR; Comerci C; Ganjam VK
    Biopharm Drug Dispos; 1986; 7(5):407-20. PubMed ID: 3535917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetic model of human insulin following different routes of administration.
    Potocka E; Baughman RA; Derendorf H
    J Clin Pharmacol; 2011 Jul; 51(7):1015-24. PubMed ID: 20940337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
    Lepore M; Pampanelli S; Fanelli C; Porcellati F; Bartocci L; Di Vincenzo A; Cordoni C; Costa E; Brunetti P; Bolli GB
    Diabetes; 2000 Dec; 49(12):2142-8. PubMed ID: 11118018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients.
    Kobayashi T; Sawano S; Itoh T; Kosaka K; Hirayama H; Kasuya Y
    Diabetes; 1983 Apr; 32(4):331-6. PubMed ID: 6339306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin pharmacokinetics following continuous infusion and bolus injection of regular porcine and human insulin in healthy man.
    Waldhäusl WK; Bratusch-Marrain PR; Vierhapper H; Nowotny P
    Metabolism; 1983 May; 32(5):478-86. PubMed ID: 6341763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption kinetics of regular insulin in dogs with alloxan-induced diabetes mellitus.
    Nelson RW; Brown SA; Jones RJ; Smith P; Bottoms GD
    Am J Vet Res; 1990 Oct; 51(10):1671-4. PubMed ID: 2240788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients.
    Shahshahani MN; Kitabchi
    J Clin Endocrinol Metab; 1978 Jul; 47(1):34-40. PubMed ID: 400713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites.
    Owens DR; Coates PA; Luzio SD; Tinbergen JP; Kurzhals R
    Diabetes Care; 2000 Jun; 23(6):813-9. PubMed ID: 10841002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption rates of subcutaneously injected insulin in the dog as calculated from the plasma insulin levels by means of a simple mathematical model.
    Fischer U; Freyse EJ; Jutzi E; Besch W; Raschke M; Höfer S; Albrecht G
    Diabetologia; 1983 Mar; 24(3):196-201. PubMed ID: 6341148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption kinetics and biologic effects of subcutaneously injected insulin preparations.
    Berger M; Cüppers HJ; Hegner H; Jörgens V; Berchtold P
    Diabetes Care; 1982; 5(2):77-91. PubMed ID: 6765510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption and miscibility of regular porcine insulin after subcutaneous injection of insulin-treated diabetic patients.
    Kølendorf K; Bojsen J; Deckert T
    Diabetes Care; 1983; 6(1):6-9. PubMed ID: 6341016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of concentration on the kinetics of SC-infused insulin. Comparison between square-wave SC infusion and bolus SC injection.
    Murat A; Slama G
    Metabolism; 1985 Feb; 34(2):120-3. PubMed ID: 3881645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of growth hormone-releasing peptide (SK&F 110679) in rat and dog following intravenous or subcutaneous administration.
    Davis CB; Crysler CS; Boppana VK; Fong KL; Joseph GL; Urbanski JJ; Macia RA; Rhodes GR
    Drug Metab Dispos; 1994; 22(1):90-8. PubMed ID: 8149896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.
    Ryysy L; Häkkinen AM; Goto T; Vehkavaara S; Westerbacka J; Halavaara J; Yki-Järvinen H
    Diabetes; 2000 May; 49(5):749-58. PubMed ID: 10905483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the absorption kinetics of subcutaneously administered insulin].
    Misawa K
    Hokkaido Igaku Zasshi; 1989 Nov; 64(6):792-812. PubMed ID: 2691384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption of NPH-insulin from subcutaneous tissue: a methodological study in pigs.
    Deckert T; Hansen B; Kølendorf K; Poulsen JS; Smith M
    Acta Pharmacol Toxicol (Copenh); 1982 Jul; 51(1):30-7. PubMed ID: 6751023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fate of porcine and human insulin at the subcutaneous injection site. I. Degradation and absorption of insulins in the rat.
    Okumura K; Komada F; Hori R
    J Pharmacobiodyn; 1985 Jan; 8(1):25-32. PubMed ID: 3891962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low subcutaneous degradation and slow absorption of insulin in insulin-dependent diabetic patients during continuous subcutaneous insulin infusion at basal rate.
    Chisholm DJ; Kraegen EW; Hewett MJ; Furler S
    Diabetologia; 1984 Aug; 27(2):238-41. PubMed ID: 6386586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of neomycin in sheep after intravenous, intramuscular, subcutaneous and intratracheal administration.
    Errecalde JO; Lanusse CE; Landoni MF
    Zentralbl Veterinarmed A; 1990 Apr; 37(3):163-9. PubMed ID: 2114710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer.
    Heinemann L; Klappoth W; Rave K; Hompesch B; Linkeschowa R; Heise T
    Diabetes Care; 2000 Sep; 23(9):1343-7. PubMed ID: 10977030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.